The Effect of C-X-C Motif Chemokine 13 on Hepatocellular Carcinoma Associates with Wnt Signaling

Figure 1

The concentration of serum CXCL13 in liver cancer patients. (a) The serum CXCL13 level in 32 HCC patients and 12 health controls detected by ELISA. CXCL13 level was much higher in stage IV HCC patients than that in other groups. There also existed statistical significance between serum CXCL13 in stage III and stages I-II group (). The horizontal lines indicate the median values for each group. (b-c) The potential correlations between CXCL13 and serum ALT and AST were analyzed by the Spearman correlation tests.

(a)

(b)

(c)